Business Context and Reporting Period
This Form 8-K filing by Autonomix Medical, Inc. (AMIX) covers the period ending November 4, 2024. The report details a corporate action involving a one-for-twenty reverse stock split completed on October 24, 2024, and a subsequent dispute regarding the issuance of fractional shares.
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a corporate governance event and a potential liability regarding share issuance.
Material Changes and Events
- Reverse Stock Split: Completed a one-for-twenty reverse stock split on October 24, 2024.
- Fractional Share Policy: The Company agreed to issue one full share to any stockholder entitled to a fractional share rather than issuing fractional shares.
- Disputed Share Request: On November 1, 2024, the Company received a notice from DTCC requesting the issuance of 271,846 shares to satisfy rounding requirements for street-name holders.
- Shareholder Count Discrepancy: The Company estimates it had approximately 4,800 shareholders of record prior to the split. Management believes the requested 271,846 shares is incorrect based on historical shareholder data and is aware of similar anomalies in recent reverse splits by other companies.
Outlook, Risks, and Contingencies
- Investigation: The Company has initiated an inquiry into the calculations provided by DTCC and brokerage firms.
- Issuance Hold: During the inquiry, the Company does not intend to issue the requested shares.
- Legal Risk: The Company acknowledges potential liability if it is ultimately determined that it was required to issue the disputed shares.
Investor Verification Checklist
- Verify the final outcome of the Company's inquiry into the DTCC share calculation request.
- Monitor for any legal proceedings or settlements related to the potential liability for non-issuance of shares.
- Confirm the updated number of outstanding shares and shareholders of record following the resolution of the dispute.
- Review subsequent filings for any impact on the Company's capital structure or cash reserves due to this event.